Human PON2 gene at 7q21.3: Cloning, multiple mRNA forms, and missense polymorphisms in the coding sequence

Gene

Volumn 213, Issue 1-2, 1998, Pages 149-157

  Mochizuki, Hisayoshi ^a   Scherer, Stephen W ^b   Xi, Tina ^a   Nickle, David C ^a   Majer, Martin ^a   Huizenga, Jack J ^b   Tsui, Lap Chee ^b   Prochazka, Michal ^a  

^a Phoenix Epidemiol Clin Res B   (United States)

^b HOSPITAL FOR SICK CHILDREN   (Canada)

Author keywords

Alternative splicing; Amino acid variants; Exon intron structure; Paraoxonase 2

Indexed keywords

ALANINE; CYSTEINE; GLYCINE; MESSENGER RNA; SERINE;

AMINO ACID SUBSTITUTION; ARTICLE; CHROMOSOME 7Q; CODING; CONTROLLED STUDY; DNA POLYMORPHISM; GENETIC LINKAGE; HUMAN; MISSENSE MUTATION; MOLECULAR CLONING; NUCLEOTIDE SEQUENCE; OPEN READING FRAME; PRIORITY JOURNAL;

AMINO ACID SEQUENCE; ARYLDIALKYLPHOSPHATASE; BASE SEQUENCE; CHROMOSOME MAPPING; CHROMOSOMES, HUMAN, PAIR 7; CLONING, MOLECULAR; DIABETES MELLITUS, TYPE 2; DISEASE SUSCEPTIBILITY; ESTERASES; GENES; HUMANS; INSULIN RESISTANCE; INTRONS; MOLECULAR SEQUENCE DATA; OPEN READING FRAMES; POLYMORPHISM, GENETIC; RNA SPLICING; RNA, MESSENGER; SEQUENCE ALIGNMENT; SEQUENCE HOMOLOGY, AMINO ACID; TRANSCRIPTION, GENETIC;

EID: 0032526104     PISSN: 03781119     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0378-1119(98)00193-0     Document Type: Article

References (33)

1. Abbott C.A., Mackness M.I., Kumar S., Boulton A.J., Durrington P.N. Serum paraoxonase activity, concentration, and phenotype distribution in diabetes mellitus and its relationship to serum lipids and lipoproteins. Arterioscler. Thromb. Vasc. Biol. 15:1995;1812-1818.
2. Adkins S., Gan K.N., Mody M., La Du B.N. Molecular basis for the polymorphic forms of human serum paraoxonase/arylesterase: glutamine or arginine at position 191, for the respective A and B allozymes. Am. J. Hum. Genet. 52:1993;598-608.
3. Altshul S.F., Gish W., Miller W., Myers E.W., Lipman D.J. Basic local alignment search tool. J. Mol. Biol. 215:1990;403-410.
4. Blatter M.-C., James R.W., Messmer S., Barja F., Pometta D. Identification of a distinct human high-density lipoprotein subspecies defined by a lipoprotein-associated protein, K-45. Identity of K-45 with paraoxonase. Eur. J. Biochem. 211:1993;871-879.
5. Boden G. Role of fatty acids in the pathogenesis of insulin resistance and NIDDM. Diabetes. 46:1997;3-10.
6. Boden G., Jadali F., White J., Liang Y., Mozzoli M., Chen X., Coleman E., Smith C. Effects of fat on insulin-stimulated carbohydrate metabolism in normal men. J. Clin. Invest. 88:1991;960-966.
7. Crackover M.A., Scherer S.W., Rommens J.M., Hui C.C., Poorkaj P., Soder S., Cobben J.M., Hudgins L., Evans J.P., Tsui L.-C. Characterization of the split hand/split foot malformation locus SHFM1 at 7q21.3-q22.1 and analysis of a candidate gene for its expression during limb development. Hum. Mol. Genet. 5:1996;571-579.
8. Felley C.P., Kleiber H., vanMelle G.D., Frascarolo P., Jequier E., Felber J.P. Resistance to insulin mediated glucose disposal in obese subjects: respective effect of lipid metabolism and glycemia. Int. J. Obesity. 16:1992;185-191.
9. Hassett C., Richter R.J., Humbert R., Chapline C., Crabb J.W., Omiecinski C.J., Furlong C.E. Characterization of cDNA clones encoding rabbit and human serum paraoxonase: the mature protein retains its signal sequence. Biochemistry. 30:1991;10141-10149.
10. Hegele R.A., Brunt J.H., Connelly P.W. A polymorphism of the paraoxonase gene associated with variation in plasma lipoproteins in a genetic isolate. Arterioscl. Thromb. Vasc. Biol. 15:1995;89-95.
11. 1166 variant of the angiotensin II type 1 receptor gene. Biochem. Biophys. Res. Commun. 213:1995;725-729.
12. Humbert R., Adler D.A., Disteche C.M., Hassett C., Omiecinski C.J., Furlong C.E. The molecular basis of the human serum paraoxonase activity polymorphism. Nature Genet. 3:1993;73-76.
13. Kelly D.E., Mokan M., Simoneau J.-A., Mandarino L.J. Interaction between glucose and free fatty acid metabolism in human skeletal muscle. J. Clin. Invest. 92:1993;91-98.
14. Kelso G.J., Stuart W.D., Richter R.J., Furlong C.E., Jordan-Starck T.C., Harmony J.A.K. Apolipoprotein J is associated with paraoxonase in human plasma. Biochemistry. 33:1994;832-839.
15. Kuo C.L., La Du B.N. Comparison of purified human and rabbit serum paraoxonases. Drug Metab. Dispos. 23:1995;935-944.
16. Lennon G., Aufray C., Polymeropoulos M., Soares M.B. The I.M.A.G.E. Consortium: an integrated molecular analysis of genomes and their expression. Genomics. 33:1996;151-152.
17. Lillioja S., Mott D.M., Spraul M., Ferraro R., Foley J.E., Ravussin E., Knowler W.C., Bennett P.H., Bogardus C. Insulin resistance and insulin secretory dysfunction as precursors of non-insulin-dependent diabetes mellitus. N. Engl. J. Med. 329:1993;1988-1992.
18. Mackness M.I., Durrington P.N. HDL, its enzymes and its potential to influence lipid peroxidation. Atherosclerosis. 115:1995;243-253.
19. Mackness M.I., Arrol S., Abbott C., Durrington P.N. Protection of low-density lipoprotein against oxidative modification by high-density lipoprotein associated paraoxonase. Atherosclerosis. 104:1993;129-135.
20. Mackness M.I., Harty D., Bhatnagar D., Winocour P.H., Arrol S., Ishola M., Durrington P.N. Serum paraoxonase activity in familial hypercholesterolaemia and insulin-dependent diabetes mellitus. Atherosclerosis. 86:1991;193-199.
21. Primo-Parmo S.L., Sorenson R.C., Teiber J., La Du B.N. The human serum paraoxonase/arylesterase gene (PON1) is one member of a multigene family. Genomics. 33:1996;498-507.
22. Prochazka, M., Thompson, D.B., Knowler, W.C., Bennett, P.H., Bogardus, C., Scherer, S.W., Tsui, L.-C., 1995a. Linkage and association of markers at 7q21.3-q22.1 with non-insulin-dependent diabetes mellitus (NIDDM) in Pima Indians. Cytogenet. Cell Genet. 71: 30. [Abstract].
23. Prochazka, M., Thompson, D.B., Scherer, S.W., Tsui, L.-C., Knowler, W.C., Bennett, P.H., Bogardus, C., 1995b. Linkage and association of insulin resistance and NIDDM with markers at 7q21.3-q22.1 in the Pima Indians. Diabetes 44 (Supplement 1): 42A. [Abstract].
24. Prochazka M., Mochizuki H., Baier L.J., Cohen P.T.W., Bogardus C. Molecular and linkage analysis of type-1 protein phosphatase catalytic beta-subunit gene: lack of evidence for its major role in insulin resistance in Pima Indians. Diabetologia. 38:1995;461-466.
25. Rommens, J.M., Mar, L., McArthur, J., Tsui, L.-C., Scherer, S.W., 1994. In: Hochgeschwender, U., Gardiner, K. (Eds.), The Identification of Transcribed Sequences. Plenum Press, New York, NY, pp. 65-79.
26. Rowles J., Scherer S.W., Xi T., Majer M., Nickle D.C., Rommens J.M., Popov K.M., Harris R.A., Riebow N.L., Xia J., Tsui L.-C., Bogardus C., Prochazka M. Cloning and characterization of PDK4 on 7q21.3 encoding a fourth pyruvate dehydrogenase kinase isoenzyme in human. J. Biol. Chem. 271:1996;22376-22382.
27. Saha N., Roy A.C., Teo S.H., Tay J.S.H., Ratnam S.S. Influence of serum paraoxonase polymorphism on serum lipids and apolipoproteins. Clin. Genet. 40:1991;277-282.
28. Scherer, S.W., Tsui, L.-C., 1991. Cloning and analysis of large DNA molecules. In: Adolph, K.E. (Ed.), Advanced Techniques in Chromosome Research, Chapter 2. Marcel Dekker, New York, NY, pp. 33-72.
29. Scherer S.W., Poorkaj P., Massa H., Soder S., Allen T., Nunes M., Geshuri D., Wong E., Belloni E., Little S., Zhou L., Becker D., Kere J., Ignatius J., Niikawa N., Fukushima Y., Hasegawa T., Weissenbach J., Boncinelli E., Trask B., Tsui L.-C., Evans J.P. Physical mapping of the split hand/split foot locus on chromosome 7 and implication in syndromic ectrodactyly. Hum. Mol. Genet. 3:1994;1345-1354.
30. Scherer S.W., Rommens J.M., Vandenberg A., Traverso G., Evans J.P., Mar L., Osborne L., Tsui L.-C. Physical and transcriptional map of a 25-mb region on human chromosome 7 (region q21-q22). Cytogenet. Cell Genet. 71:1995;22.
31. Scherer S.W., Tompkins B.J.F., Tsui L.-C. A human chromosome 7-specific genomic DNA library in yeast artificial chromosomes. Mammal. Genome. 3:1992;179-181.
32. Sorenson R.C., Primo-Parmo S.L., Kuo C.-L., Adkins S., Lockridge O., La Du B.N. Reconsideration of the catalytic center and mechanism of mammalian paraoxonase/arylesterase. Proc. Natl. Acad. Sci. USA. 92:1995;7187-7191.
33. Watson A.D., Berliner J.A., Hama S.Y., La Du B.N., Faull K.F., Fogelman A.M., Navab M. Protective effect of high density lipoprotein associated paraoxonase. Inhibition of the biological activity of minimally oxidized low density lipoprotein. J. Clin. Invest. 96:1995;2882-2891.